Background: Pouchitis occurs in up to 50% of patients with ulcerative colitis (UC) undergoing Heal pouch anal anastomosis (IPAA). Pouchitis rarely occurs in patients with familial adenomatous polyposis (FAP) who undergo IPAA. Our aim was to compare mucosal and luminal flora in patients with UC-associated pouchitis (UCP), healthy UC pouches (HUC), and healthy FAP pouches (FAP).
I Inflammation of the ileal pouch, termed pouchitis, is the most common long-term complication in patients with UC who undergo IPAA. 2 Pouchitis occurs in up to 50% of these patients 3 ' 4 and is the major factor leading to morbidity after IPAA surgery in patients with UC. 3 ' t In comparison to individuals with a history of UC, those undergoing IPAA for FAP are far less likely to develop pouchitis. 5 The pathogenesis of pouchitis is incompletely understood. Proposed etiologies include fecal stasis, bacterial overgrowth, dysbiosis, genetic susceptibility, short-chain fatty acid deficiency, ischemic complications of surgery, bile-acid toxicity, immune alteration, a missed diagnosis of Crohn's disease (CD), or a recurrence of UC in the pouch. prophylactic benefit with probiotic therapy. 1° A therapeutic utility of both antibiotics and probiotics suggests there may be subtle shifts in pouch microflora that culminate in pouch inflammation.
Recently, Komanduri et al l ' described a pouch dysbiosis in five patients with UC and pouchitis when compared to patients with UC and no pouchitis and to healthy ileal tissue in continuity with the colon. Inflamed pouch mucosa was found to have greater bacterial species diversity than pouch control or healthy ileal tissue. Fusobacterium varium was more abundant in pouchitis tissue, while Streptococcus species were dramatically reduced. Healthy UC pouches possessed a unique floral pattern, with more representatives from the Clostridium, Enteric, and Streptococcus groups compared to ileal tissue from healthy subjects.
In our study we aimed to characterize both mucosal and luminal microflora in inflamed UC pouches compared to healthy UC and FAP pouches. We designed the study with FAP pouch control subjects in an effort to find shifts in flora that were distinct to UC and inflammation rather than fecal stasis. We utilized 16S ribosomal DNA gene-based terminal restriction fragment length polymorphism (TRFLP) techniques to characterize luminal and mucosal microbial environments, followed by DNA sequencing for further characterization and validation.
MATERIALS AND METHODS

Patient Population
Individuals over age 18 years were enrolled from the Massachusetts General Hospital (MGH)
Gastrointestinal Unit in one of three cohorts with pouches after IPAA: those with a history of UC and subsequent pouchitis (UC pouchitis, UCP), those with a history of UC without pouchitis (healthy UC pouch, HUC), or those with a history of FAP without pouchitis (healthy FAP pouch, FAP 
Data Collection
Key clinical data collected from each patient included age, gender, disease duration and extent, pouch duration, number of pouchitis episodes in the previous year, medication use, and the clinical components of the PDAI. The PDAI clinical score takes into account stooling frequency and the presence of hematochezia, stooling urgency, abdominal cramping, and fever.
Endoscopic and histologic findings were noted for each patient and incorporated into the PDAI score.
Specimen Collection
All patients underwent pouchoscopy after clinical data were collected. Patients received a short course of bowel preparation 1 day prior to the procedure with phospho-soda. Luminal pouch contents were suctioned through the colonoscope into a sterile container. Approximately I cc of the suctioned stool was aliquoted into each of three vials containing 1 cc of 10% glycero1/90% sterile water. Tubes were inverted to generate a homogeneous mixture then immediately placed in dry ice. The pouch was examined for elements of the PDAI endoscopic score: edema, granularity, friability, loss of vascular pattern, mucous exudates, and ulceration. Then three biopsies were taken at the most inflamed sites or at random locations from normal-appearing tissue. Each tissue specimen was immediately rinsed in normal saline then placed in a vial containing 1 cc of 10% glycerol/90% sterile water. The vials were inverted to submerge the tissue specimen then immediately placed in dry ice. All specimens were then stored at -80°C within
TRFLP Analysis
All stool and tissue specimens were analyzed by TRFLP at the Environmental Biotechnology Institute at California Polytechnic State University (CPSU). DNA was isolated using MoBio's Power Soil DNA extraction kit according to the manufacturer's protocol (MoBio Laboratories, Carlsbad, CA). Triplicate 0.1-g samples were used for the extraction of stool samples, while the entire biopsy sample was used for the isolation of DNA from tissue samples.
Bacterial 16S ribosomal RNA genes were amplified from both types of sample using the Reaction temperatures and times were as follows: 95°C for 10 minutes followed by 30 cycles of 95°C for 1 minute, 60°C for 1 minute, and 72°C for 2 minutes, followed by a final extension of 72°C for 10 minutes. The quality of the extractions and polymerase chain reaction (PCR) reactions were confirmed using gel electrophoresis. PCR triplicates were combined during a PCR cleanup performed using MoBio's PCR Cleanup Kit following the manufacturer's protocol (MoBio Laboratories). PCR products were quantified using a FLX800 microplate fluorescence reader tuned to the labeling dye (Bio-Tek Instruments, Winooski, VT). [IL formamide and 0.25 tL CEQ 600 basepair standard. Terminal restriction fragments were separated using capillary gel electrophoresis and profiles were obtained using a Beckman
Coulter (Fullerton, CA) CEQ8000X DNA analysis system.
Terminal restriction fragment lengths and relative peak areas were exported from the CEQ8000 into Excel (Microsoft, Seattle, WA). TRF data consists of peak sizes, which indicate the length of the DNA fragment in nucleotides, and the area under each peak, which provide a measure of abundance for each DNA fragment. Since the amount of DNA loaded on the capillary cannot be accurately controlled, the sum of the total peak area varies between TRF patterns.
Therefore, peak areas are normalized by converting the value to parts per million to standardize the data for comparison." Peaks with an area less than 10,000 ppm (<1.0% of the total) were excluded from the analysis to reduce excess noise. Data from three independent restriction enzyme digests were included to reduce the incidence of distinct sequences with equivalent TRF lengths.
TRF fragments determined to differ most between sample groups were compared to available GenBank (Bethesda, MD) sequences to tentatively identify potential bacterial populations. TRFLP data were analyzed for peaks that could be identified by database analysis as representing particular groups of organisms.
16S Ribosomal DNA-based DNA Sequencing
Four fecal samples from each of the UCP group and the FAP group were selected for sequencing analysis of pooled DNA. Samples with the greatest intersample similarities in TRF profiles (as determined with Bray-Curtis similarity indices) were selected in an effort to create the most uniform pooled specimens representative of each patient group. DNA from the samples was processed as detailed for TRF analysis, using full-length 16S PCR primers without fluorescent label, then sent to the Broad Institute (Cambridge, MA) for sequencing.
Samples were cloned into the pCR2.1-TOPO vector and sequenced on an ABI3730 DNA sequencer.
Sequences were trimmed using LUCY. 14 Read pairs from each clone were then assembled using the following alignment-assisted assembly method implemented at the Broad Institute. A reference sequence for use as an alignment template for the read pairs was first selected from a core set of nonchimeric 16S rRNA sequences obtained from Greengenes. 15 The core set reference sequence sharing the greatest number of matching k-mers with the aggregate k-mer set of both forward and reverse reads was selected. Forward and reverse reads were each aligned to the core reference sequence using Blast. I6 Aligned forward and reverse reads were then assembled based on the alignment with base quality scores used and preserved through assembly.
For purposes of classification, only assembled sequences of greater than 1100 nucleotides were considered. Sequences were classified using a naïve Bayesian rRNA classifier." The classifier was trained on the Ribosomal Database Project core set, RDP10.
I8
Statistics
Differences in patient characteristics were assessed using Fisher's Exact test for categorical variables and the Exact Kruskal-Wallis test for continuous variables. TRFLP datasets were transformed by taking the square root of the area under each peak to deemphasize large TRFLP peaks while still accounting for relative abundance. Transformed data from UCP, HUC, and FAP groups were compared using Bray-Curtis similarity, multidimensional scaling, and analysis of similarity (ANOSIM) (Primer E, Plymouth, UK). ANOSIM was also used to compare intersubject and intrasubject TRFLP profile similarities. Analysis of variance (ANOVA) was used to compare relative abundance of specific TRFLP pattern elements between each group of subjects. Among the pooled fecal DNA samples, differences in the percentage of total identifiable clones represented by each bacterial genus were calculated using Fisher's Exact test, considering that the number of identifiable clones in a sample is proportional to species abundance.
Ethical Considerations
This study was approved by the Institutional Review Boards at MGH and CPSU.
[Insert Table 1 ]
RESULTS
Patients
A total of 19 patients were enrolled and divided into three groups: UCP (n = 9), FAP (n =. 7), and HUC (n =-3) (Table 1 ). Overall, 37% of patients were female and the average age was 40.6 years. There were no significant differences in baseline demographics or disease characteristics between the three groups. PDAI values were significantly higher in the UCP group (P < 0.001).
All mucosal biopsies in the UCP group displayed histologic evidence of active pouchitis. One UCP patient received chronic ciprofloxacin therapy for the prior 8 years and one received chronic rifaximin therapy for the prior year, both with continued episodes of pouchitis. Three UCP patients had received short courses of ciprofloxacin ranging from 3 months to 1 year prior to enrollment. The remaining four UCP patients received ciprofloxacin briefly -2 years prior to enrollment.
TRFLP Analysis
Significantly more peaks were observed in TRFLP data from mucosal samples (average total number of peaks/ sample in three digests = 64.8, standard deviation [SD] = 12.
2) compared to fecal samples (average total number of peaks/sample in three digests = 41.3, SD = 8.2) with P < 0.001 (Fig. 1) . The greatest amount of similarity existed within samples from the same person, with both mucosal and fecal sample similarity greater within a subject than between subjects (P = 0.027). There was no significant difference between patient groups in the degree of similarity between fecal and mucosal samples (P > 0.05). Between individuals, mucosal TRFLP profiles were found to be more consistent than fecal samples (P < 0.001).
TRFLP data from mucosal and fecal samples were significantly different between each of the three patient groups. [Insert Figure 1 and Figure 2] 
DNA Sequencing
In all, 2304 clones were processed for each pooled sample (4608 total clones). After data processing and analysis, good quality forward and reverse reads were identified with a reliable classification at the genus level (>80%). A total of 712 sequences were identified in the UCP pooled sample and 1015 in the FAP pooled sample.
At the phylum level, the UCP pooled sample revealed significantly more Firmicutes and Verrucomicrobia (52% and 22% of clones, respectively) compared to the FAP group comprised of 19% Firmicutes and 3% Verrucomicrobia (P < 0.001 and P < 0.001, respectively).
However, numbers of clones in the Bacteroidetes phylum were significantly higher in the FAP group (71% of clones) compared to UCP (20% of clones, P < 0.001). There were no significant differences between pooled samples among the Fusobacteria, Proteobacteria, and Actinobacteria phyla ( Table 2 ). [Insert Table 2] Multiple bacterial genera within the class Clostridia were significantly more prominent in the UCP group compared to the FAP group (Table 3) . Among Clostridia, the UCP group had more clones represented by the genera Roseburia (8% of clones in UCP versus near 0% in FAP, P < 0.001), Lachnospiraceae Incertae Sedis (28% versus 10%, P < 0.001), Clostridium (9% versus 1%, P < 0.001), Lachnospira (2% versus 0, P < 0.001), and Veillonella (3% versus near 0%, P < 0.001). The UCP pooled sample also had more clones from the genus Prevotella than the FAP group (6% versus 1%, P < 0.001). Finally, the UCP group revealed 22% of its pooled clones from the genus Akkermansia in the phylum Verrucomicrobia, compared to only 3% in FAP (P < 0.001).
Members of the genus Bacteroides predominated in the pooled fecal sample of the FAP group, with 678 of 1015 (67%) clones representing Bacteroides, compared to 99 of 712 (14%)
in UCP (P < 0.001). Other genera that were statistically more prominent in the FAP group were Faecalibacterium in the family Ruminococcaceae (6% of clones in FAP, 0% in UCP, P < 0.001), Parabacteroides (2% in FAP, 0% in UCP, P < 0.001), and Escherichia (2% in FAP, 0% in UCP, P < 0.001).
DISCUSSION
The results of our study suggest that the pouch microbial environment is distinctly different between patients with UC-associated pouchitis and healthy UC or FAP pouches. Using 16S ribosomal gene-based TRFLP data, we identified significant differences in bacterial communities between all three patient cohorts in both stool and mucosa. These broad differences in TRFLP profiles were further explored using DNA sequencing. Sequencing revealed multiple statistically significant variations in specific bacterial genera between pooled fecal DNA from a subgroup of patients with UCP and a subgroup of patients with FAP.
We report data that supports previously published work suggesting a dysbiosis is central to pouchitis. Using length-heterogeneity PCR followed by sequencing, they concluded that inflamed pouch mucosa had greater species diversity and more Fusobacterium varium than healthy UC pouches or healthy deal tissue in continuity with the colon. Noninflamed UC pouches revealed more representatives from the Clostridium, enteric, and Streptococcus groups compared to pouchitis and healthy nonpouch Heal tissue. These differences between UC and health could be explained by the fact that the healthy ileal tissue was in continuity with the colon without fecal stasis. In each of these studies the healthy pouch control subjects suffered from UC, without any non-inflammatory bowel disease (IBD) pouch controls.
Our study was designed to utilize molecular techniques to identify bacterial populations unique to inflamed or healthy UC pouches compared to a non-IBD pouch, keeping pouch fecal stasis as a consistent factor across all patient groups. This design and our findings differed from the results of Komanduri et al. 1 ' We found no increase in Fusobacterium species among inflamed pouches and instead noted the largest numbers of Clostridium species in the UCP group. We also noted a unique reduction in Bacteroides in the inflamed pouch compared to FAP. Our findings suggest that a mucosal and luminal dysbiosis exists in pouchitis, not only when compared to the healthy UC pouch but also when compared to a non-IBD pouch. Additionally, healthy UC pouches differed significantly from FAP pouches. This suggests an alteration in ileal pouch microbiota that may be unique to the UC disease state, with or without inflammation.
Our TRFLP results supported an overall increase in fecal Clostridium in UCP patients compared to FAP patients. This finding may be consistent with those of Falk et al. 25 DNA sequencing confirmed our findings, with the genus Clostridium representing 9% of identifiable clones in the UCP pooled sample compared to only 1% in the pooled FAP sample. More broadly, the class Clostridia accounted for 53% of identifiable clones in the UCP group compared to 21% in the FAP group. The genus Eubacterium was also more prevalent in the UCP stool by TRFLP, but no known Eubacterium species were revealed by sequencing. This may be due to the difficulty of TRFLP to distinguish between Eubacterium and Clostridium species. The decrease in Lactobacillus and Streptococcus genera in UCP compared to FAP pouches also was not reflected in the sequencing data. However, this is not surprising since the number of clones identified as representing Lactobacillus and Streptococcus was less than 0.5% of the total identified. These disparities between TRFLP and sequencing results could be explained by our sampling only four patients from each group for sequencing. Importantly, TRFLP is best used to compare bacterial community structure between samples and is less precise than sequencing analysis for bacterial speciation. 26 Sequencing results revealed an overall decrease of the phylum Bacteroidetes in the inflamed pouch. This finding is consistent with multiple molecular surveys of intestinal microbiota in both CD and UC. 27-3° Bacteroidetes play a key role in maintaining gut health, so it has been proposed that a relative reduction in this population may favor the development of inflammation. This study has certain limitations. TRFLP is best used to compare bacterial community structure between cohorts and is not precise in identifying species. Thus, the results of TRFLP should be interpreted as suggestive of bacterial groups, rather than specific species, and emphasis should be placed on the separation between each group. The study may have found more differences between patient groups if the sample size had been larger. Nevertheless, we were able to identify statistically significant differences in TRFLP data and clone libraries between groups.
Another limitation was the pooling of DNA into groups for DNA sequencing. Individual sequencing of each sample was limited due to expense. This may have led to an apparent difference in flora between groups if only one sample had a unique bacterial profile. However, we grouped samples with similar TRFLP data in an effort to minimize the chance of one sample skewing the analysis. Additionally, the use of antibiotics in UCP patients may have altered gut flora. However, TRFLP profiles were similar in all UCP patients and distinct compared to HUC and FAP, regardless of whether the subjects had received antibiotics chronically or briefly 1-2 years before enrollment. This suggests that the dysbiosis may be unique to pouchitis and not a direct result of exposure to antibiotic medications.
In conclusion, we identified differences in the pouch microbiome between the inflamed pouch in UC, the healthy pouch in UC, and the healthy pouch in FAP. These differences in bacterial populations were evident in stool and mucosa by TRFLP analysis. 16S rDNA sequencing revealed specific differences in luminal bacterial genera, with the pouchitis group having substantially fewer Bacteroidetes and more Clostridia compared to the healthy FAP group. These findings reinforce other surveys of the micro-biome in both UC and CD. Additionally, one genus with flagellated species and one genus with mucin-degrading species were more prevalent in the pouchitis group, thus raising TLR5 activation and mucin degradation as possible factors in the pathogenesis of pouchitis. These results suggest that a dysbiosis may exist in both the inflamed and noninflamed UC pouch which may be central to understanding UC. 1 . Example of raw TRFLP data. TRFLP data (Hpa digest) from one patient (stool and mucosal samples) illustrating the difference in diversity made apparent by TRFLP. Each peak represents one or more taxonomic unit(s) of bacteria defined by the single TRF length. Note the increased number of peaks in the mucosal sample.
FIGURE 2.
Multidimensional scaling (MDS) analysis of TRFLP data. MDS analysis compares complex profiles, here TRFLP peaks, in two-dimensional space with the most similar profiles being closest spatially and those most dissimilar being farthest apart. Each shape represents one patient's TRFLP profile. Differences between groups were evaluated using ANOSIM. P-values for each comparison are listed.
